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Abstract
Photodynamic Therapy (PDT) has emerged as a useful cancer treatment modality which utilizes a tumor localizing dye
and activating light to selectively destroy neoplastic tissue. Inan effort to understand the newly synthesized photosensitiz-
ers, we are studying them ina mouse tumor model grown on the dorsal side of the foot by in vivo magnetic resonance tech-
niques. We have synthesized several photosensitizers which are specifically labeled withfluorine. Several coils appropriate
for the tumor study by 19F NMR were designed and constructed for this project. The solenoid coil tunable to both JHand
19Fnuclei was used to monitor the 19Flabeled photosensitizer in the mouse foot tumor. An in vivo 19F NMR technique was
used to study the retention of the photosensitizer over time in the tumor. We have used 31P NMR to study the outcome of
PDT after using the new photosensitizer.
Introduction
Magnetic resonance spectroscopy (MRS) and magnetic
resonance imaging (MRI)have significant impact on both
)asic research and clinical applications due to their non-
nvasive nature and sensitivity to molecular structure,
nteractions, and mobility. Additionally, MRS can be quan-
titative under proper conditions and MRI can provide
morphological images.
Photodynamic Therapy (PDT) is an expermimental can-
cer treatment modality which selectively destroys cancer
ells by interaction of light with a photosensitizing dye,
jresumably via singlet oxygen formation (Weishaupt et al.,
976). There are, however, some questions which need
answers, such as 1) the time period for which photosensi-
izers are retained in the tumor, and 2) the optimum time
at which laser irradiation can ve initiated. A non-invasive
way of monitoring the photosensitizer in the tumor would
>e useful in PDT studies and magnetic resonance is one
uch useful tool.
Extensive research on photosensitizer localization in
ancerous tissue has been reported (Kessel and Chou,
983; Dougherty et al., 1984; Swincer et al., 1984).
Researchers have detected the presence of photosensitiz-
rs incells (Bottiroli et al., 1984; Moan, 1984) using their
luorescence properties. The measurements of absolute
oncentration of the photosensitizers in vivo have been
attempted and have been found tobe extrememly difficult
because of the dependence of fluorescence efficiency on
the tumor tissue, and due to the fact that the fraction of
detected emitted photons depends upon the tissue type,
the source, and the detector geometry.
Monitoring the effect ofPDT through invivo 31P MRS
has been used in biomedical in vivo sutdies, and this
method has revealed alterations in energy and phospho-
lipid metabolism before and after laser irradiation.
Ceckler et al. (1986) have reported dramatic and often
near complete decreases innucleoside triphosphate (NTP)
peaks accompanied by significant increase in inorganic
phosphate (Pi) within four hours of PDT treatment.
Completely non-invasive MR can provide a measure of the
concentration of the photosensitizers and their metabo-
lites within tumors. Detailing pharmacokinetics and drug
concentrations within the tumor willhelp determine the
minimum doses to insure the fewest side effects for
humans undergoing PDT. These studies will aid in the
development of a more effective protocol for humans.
In this paper we willdiscuss: 1) the design and fabrica-
tion of RF coils for MRS and MRI tumor studies, 2) tumor
bioenergetics monitored by 31P MRS, and 3) the detection
of the 19F labeled photosensitizers in radiation induced
fibrosarcoma (RIF) tumors in vivo. We chose fluorine as
the labeled element because the 19Fisotope has 100% nat-
ural abundance, a spin of 1/2, and an NMRsensitivity that
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is 83% that ofhydrogen. Invivo studies ofporphyrin pho-
tosensitizers are very limited. In fact, to our knowledge,
there are no known reports of invivoMR studies attempt-
ing to detect such sensitizers in cancerous or non-cancer-
ous tissue. Comprehensive knowledge of the extent of
localization and the rate of accumulation is of immense
value in PDT.
Materials and Methods
MRSand MRICoils.—Figure 1A shows an air core sole-
noid coil with four equally spaced turns which is 1.5 cm in
diameter and 2.1 cm in length. Inorder to tune to the res-
onance frequencies for both *Hand 19F and to insure a
good circuit quality factor, Q, we mounted the copper
wire on a Plexiglas (Rohm and Haas, Canada, Inc.) insula-
tor. The fixed capacitors were 2.5 pF (Dielectric
Laboratories, Inc.) Inorder tomaximize the tuning range,
we had to minimize the scattering capacitance and any
connector resistance. Frequency properties were mea-
sured with a Wiltron 6400 Series RF Network Analyzer.
Fig. 1A. The dimensions of the solenoid coil
IB.The dimensions of the Helmholtz coil
Helmholtz Coil.
—
To insure a uniform imaging region for
the tumor studies, the diameter and the length of the coil
were optimally designed. The diameter, d, was chosen
approximately equal to the length, a, (d = 4.2 cm; a ¦ 4.2
cm), tomaximize the homogeneity of the fieldregion. Fig.
IBshows the geometric design of the Helmholtz coil.The
coil was constructed by first winding a 3.30 mm wide by
0.08 mm thick adhesive backed copper foilon the cylin-
drical fluorine free tubing. The coil was glued to a
Plexiglas plate to avoid any movement which adversely
would effect the resonant frequency. Allconnections were
short to minimize the resistance and scattering capaci-
tance. Also, weused fluorine free capacitors and materials.
PDT on the RIF Tumor.
—
Fresh RIF cells were injected
into the flank of male mice (C3H/HeN). After an appro-
priate tumor size was reached, it was cut open and a small
piece of the tumor was implanted on a mouse foot. A
mouse foot tumor of proper size (400-600 mm3 for imag-
ing and spectroscopy) was obtained after 10 to 15 days.
Several background control spectra were collected with
only the coil and the coil with a typical tumor. No fluorine
peaks were observed. The 19Flabeled photosensitizer com-
pound was dissolved in distilled water and the spectrum
was recorded in the GE 4.7T animal imager using the sole-
noid coil in the balanced configuration. The photosensi-
tizer was injected IP (25 mg/kg) and after 24 hours PDT
treatment was initiated wtih a laser power of 150
mW/cm 2. The total light energy was 50-100 joules at the
photosensitizer absorption wavelength of 630 nm. The
Ar+ CW pumped dye laser output was coupled via an opti-
cal fiber in the PDT experiment. All S1P spectra were
obtained on a General Electric 4.7T animal imaging sys-
tem. Ahome-built phosphorus coil was used inacquiring
spectra. Labeled 19F photosensitizer was detected in vivo
by using the home-built balanced solenoid coil.
Results and Discussion
Comparison of the Balanced and Unbalanced
Coils.
—
The coilconfiguration is a very important factor in
determining the frequency response of both the solenoid
coiland the Helmholtz coil. Both the balanced and unbal-
anced configurations of the solenoid coil (as shown in
Figs. 2A, 2B) were tested. The balanced coil was found to
be more symmetrical about its resonant frequency com-
pared to the unbalanced coil.
CoilPerformance Tests Using Phantom.
—
The purpose
of building coils tunable to both lHand 19F nuclei was to
perform proton imaging, as well as fluorine spectroscopy
or imaging, using the same coil without disturbing the ani-
mal. In addition it also helps in shimming the region of
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interest using the proton frequency since all biological
samples have large amounts of water, whereas, the amount
of naturally occurring fluorine compounds are so small,
they give no background signal. Furthermore, to obtain
fluorine signals from a localized region of interest, we
need proton images as a reference or guide.
Fig. 2A. Schematic of the unbalanced coil
2 B.Schematic of the balanced coil
A phantom is an ideal sample for testing the imaging
and spectroscopic properties of the doubly-tuned coil.
rig.3 shows the phantom images for the balanced solenoid
coil in both the axial and sagittal directions and Fig. 4
hows the sagittal image from the Helmholtz coil. From
hese images, we concluded that the solenoid coil was not
uitable for the imaging studies. The Helmholtz coil has a
very good homogenous imaging region which is large
enough for the mice foot tumor studies.
31PMR Studies.
—Fig. 5 shows the 31P spectrum of a
mouse foot tumor before the PDT. Figs. 6 and 7 show 31P
Dectra recorded 20 min and 17 h after PDT. While small
4TP peaks persist at the end of 20 min, the NTP peaks
lave disappeared at the end of 17 h indicating that all of
\e cancer cells have been killed. These results are similar
o those of Ceckler et al. (1986). After three days, the RIF
tumors on the mice feet stopped growing and began to
shrink. After six days the tumors had disappeared totally.
Detection of 19FLabeled Drugs in the Tumor.
—
Our pre-
liminary studies on the 19Flabeled photosensitizer indicate
that they can be non-invasively monitored by NMR spec-
troscopy. InFig. 8 we show the first labeled photosensitiz-
er peak fivehours after direct injection of the labeled com-
pound. This method ofdetecting and monitoring the pho-
tosensitizer is the first of its kind and this technique holds
much promise for PDT research.
Fig. 4. The homogeneity of the Helmholtz coil proton
imaging. Total length is about 1.5 cm, which is long
enough for our project.
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Ij.5. 31P-NMR spectrum of RIF tumor 24 hrs after theection of 25 mg/kg of a photosensitizer, prior to PDT.ectrum was obtained using 900 scans, a 90° pulse of 13repetition time of 1 sec, and a total accumulation time
min.
ppm
Fig. 6. 31P-NMR spectrum of the RIF tumor 20 min after
PDT, under same experimental conditions as prior to
Fig. 7. 31P-NMR spectrum of the RIF tumor 17 hr after
PDT under same experimental conditions as prior to PDT.
ppm
Fig. 8. The in vivo detection of 19F-labeled drug in mice
RIF tumor five hrs after injection. The parameters were:
data size 8k, 7200 accumulations, repetition time 300 ms,
a 10 us 90° pulse, 19F transmitter center at 188.26 MHz,
total accumulation time of 36 min.
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Conclusions
The balanced RF coil configuration gave good frequen-
cy response, high Q values, and exhibited good linear
phase properties. The solenoid coil has enough sensitivity
and the Helmholtz coil has enough homogeneity to study
tumor sizes in the range 300-600 mm.3 The fluorine
labeled compound studied displayed the properties of a
good photosensitizer on RIF tumors inmice feet. 31p spec-
troscopy appears tobe a useful method for monitoring the
tumor bioenergetics before and after PDT which can be
helpful in evaluating photosensitizers invivo. Preliminary
invivo results on the 19F labeled photosensitizers are very
promising to study the photosensitizer uptake, retention,
and possibly the extent of localization.
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